Design, synthesis and cytotoxicity evaluation of pyrazolyl pyrazoline and pyrazolyl aminopyrimidine derivatives as potential anticancer agents
作者:Raquib Alam、Aftab Alam、Amulya K. Panda、Rahisuddin
DOI:10.1007/s00044-017-2082-8
日期:2018.2
In an attempt to find bio-active heterocyclic analogues, a series of novel 1-(5-(3-(aryl)-1-phenyl-1H-pyrazol-4-yl)-3-(pyridin-3-yl)-4,5-dihydropyrazol-1-yl)ethanones 5a–i and 4-(3-(aryl)-1-phenyl-1H-pyrazol-4-yl)-6-(pyridine-3-yl)pyrimidin-2-amines 6a–i were designed, synthesized, and evaluated for their in vitro cytotoxicity against a panel of human cancer cell lines namely, HeLa (human cervix),
为了寻找具有生物活性的杂环类似物,一系列新型的1-(5-(3-(芳基)-1-苯基-1 H-吡唑-4-基)-3-(吡啶-3-基) -4,5-二氢吡唑-1-基)乙炔5a-i和4-(3-(芳基)-1-苯基-1 H-吡唑-4-基)-6-(吡啶-3-基)嘧啶-设计,合成了2-胺6a-i,并评估了其对一组人类癌细胞系HeLa(人宫颈),NCI-H460(人肺),PC-3(人前列腺)的体外细胞毒性,和NIH-3T3(小鼠胚胎成纤维细胞)细胞系。这些化合物中的大多数对被测试的癌细胞系表现出中等至良好的细胞毒性,而对正常细胞系则表现出微弱的毒性。类似物5f,5g,5i,与标准药物依托泊苷相比,6b–g显示出明显的细胞毒性。化合物6g对Hela癌细胞系表现出优异的活性,IC 50值为5.47±0.44 µM。